STONEGATE INVESTMENT GROUP, LLC – BioCryst Pharmaceuticals, Inc. Transaction History
STONEGATE INVESTMENT GROUP, LLC portfolio value:
$617,000
portfolio value
STONEGATE INVESTMENT GROUP, LLC quarter portfolio value change:
+19.09%
quarter
BioCryst Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 99K | $12.6 | 48.98K | |
| Q2 2022 | share | 0.00% | 0 shares | -279K | $10.58 | 48.98K | |
| Q1 2022 | share | 0.00% | 0 shares | 119K | $16.26 | 48.98K | |
| Q4 2021 | share | Increase | 0.00% | 48.98K shares | 678K | $13.79 | 48.98K |